Moreover, mutation of BRAF were frequently identified in various cancers, including melanoma, non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma (53–57). This evidence concerns the gene BRAF and thyroid gland carcinoma.